Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angocin Anti-Infekt N for prophylaxis of respiratory tract infections
2010-023227-26Phase 3Completed
- Sponsor
- Repha
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Angocin Anti-Infekt N in Airways Infection (3 arms), sponsored by Repha. Started Nov 2010; status: completed.
02
Drugs
Angocin Anti-Infekt N
03
Conditions
Airways Infection
Beyond the preview
Go deeper on 2010-023227-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023227-26.